IFPMA Report on Future Antibiotic Pipeline
The IFPMA report “From Resistance to Resilience” underscores the urgent need to address antimicrobial resistance (AMR), a major global health threat leading to millions of deaths annually. The study explores two future scenarios for antibiotic development: without new incentives, only a few treatments progress significantly; with strong incentives by 2025, many more treatments could be developed, significantly reducing AMR-related diseases. Economic incentives, particularly pull incentives, are crucial. The role of small and medium-sized enterprises (SMEs) in research and development is highlighted, with calls for increased policy support to bolster the antibiotic pipeline and enhance global health security.
